Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (319) Arrow Down
Filter Results: (319) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (495)
    • People  (2)
    • News  (79)
    • Research  (319)
  • Faculty Publications  (185)

Show Results For

  • All HBS Web  (495)
    • People  (2)
    • News  (79)
    • Research  (319)
  • Faculty Publications  (185)
← Page 11 of 319 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • 22 Aug 2005
  • Research & Ideas

The Hard Work of Failure Analysis

the folly of not adhering strictly to the company's core beliefs.2 Similarly, we have observed failed consulting relationships in our field research in which the consultants simply blamed the failure on the client, concluding that the... View Details
Keywords: by Amy Edmondson & Mark D. Cannon
  • 25 Feb 2014
  • First Look

First Look: February 25

the weakening of democratic governance and the politics of decisions about industrial policy. Publisher's link: http://www.psupress.org/books/titles/978-0-271-05631-9.html August 2013 Research Policy Digital Dark Matter and the Economic... View Details
Keywords: Sean Silverthorne
  • 17 Mar 2009
  • First Look

First Look: March 17, 2009

Agreements in Bio-Pharmaceuticals Authors:Juan Alcácer, John Cantwell, and Michelle Gittelman Publication:In Location of Biopharmaceutical Activity, edited by Iain M. Cockburn and Matthew J. Slaughter. NBER, forthcoming. Abstract As the value chain of the View Details
Keywords: Martha Lagace
  • 22 Oct 2013
  • First Look

First Look: October 22

expenditures on teammates lead to better performance in both sports teams in Canada and pharmaceutical sales teams in Belgium. These results suggest that a minor adjustment to employee bonuses-shifting the focus from the self to... View Details
Keywords: Sean Silverthorne
  • 04 May 2010
  • First Look

First Look: May 4

Reexamination of Tunneling and Business Groups: New Data and New Methods Authors:Jordan I. Siegel and Prithwiraj Choudhury Abstract The last decade of corporate governance research has been focused in large part on identifying what leads... View Details
Keywords: Martha Lagace
  • 15 Jan 2013
  • First Look

First Look: January 15

and Use of a New Accounting System Authors:Narayanan, V.G., Ranjani Krishnan, and Jamshed J. Mistry Publication:Journal of Management Accounting Research Abstract This study examines the attitudes, use, and acceptance of a new accounting... View Details
Keywords: Sean Silverthorne
  • 12 Nov 2013
  • First Look

First Look: November 12

  Publications November 2013 Journal of Consumer Research The Red Sneakers Effect: Inferring Status and Competence from Signals of Nonconformity By: Bellezza, Silvia, Francesca Gino, and Anat Keinan Abstract—We examine how people react to... View Details
Keywords: Sean Silverthorne
  • 05 May 2015
  • First Look

First Look: May 5

causes considerable societal damage, as demonstrated by increasing empirical evidence. Drawing on recent research in moral psychology and behavioral ethics, I examine "moral flexibility," or the common ability to justify one's... View Details
Keywords: Carmen Nobel
  • 27 May 2009
  • First Look

First Look: May 27, 2009

Case 509-048 The case describes the effort of Merck, a global leader in pharmaceuticals, in making available its medicines to the poor. The challenge for the company (or for that matter, any pharmaceutical company) is how to integrate its... View Details
Keywords: Martha Lagace
  • 23 May 2017
  • First Look

First Look at New Ideas and Research: May 23, 2017

difficult to understand and implement. We introduce the 4 Minds framework as a practical tool for understanding and applying the science of decision-making in the marketplace. We synthesize previous research on decision-making into four... View Details
Keywords: Carmen Nobel
  • 15 Jan 2018
  • Research & Ideas

A Better Business Model for Fighting Cancer

iPhoto With billions of dollars spent on the development of precision medicine and related cancer research over the last decade, a recent partnership seeks a new way to bring these treatments to patients more quickly: through a better... View Details
Keywords: by Julia Hanna; Pharmaceutical; Pharmaceutical
  • Research Summary

Overview

By: Andy Wu
How can technology entrepreneurs build competitive advantage from the ground up? Professor Andy Wu conducts scholarly research and develops course materials that document how technology entrepreneurs can (1) organize for innovation to create new market opportunities... View Details
Keywords: Strategy; Entrepreneurship; Venture Capital; Growth Management; Organizational Design; Organizational Structure; Technology Platform; Technological Innovation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States; China; Southeast Asia; South Asia
  • 25 Apr 2005
  • Research & Ideas

New Learning at American Home Products

pharmaceutical companies in 1984, American Home Products ranked first in sales and twenty-eighth in R&D expenditures as a percentage of sales.23 As the historian Williams Haynes noted, by the end of the 1930s, American Home Products... View Details
Keywords: by Alfred D. Chandler Jr.; Pharmaceutical; Pharmaceutical; Pharmaceutical; Pharmaceutical
  • 10 Sep 2008
  • Research & Ideas

Long-Tail Economics? Give Me Blockbusters!

by focusing on bigger films that require a bigger commitment." Jeff Robinov believes in blockbusters and his strategy is to create more of them. The pharmaceutical and entertainment industries are similar. R&D costs in both are... View Details
Keywords: by John Quelch; Pharmaceutical; Pharmaceutical
  • 20 Nov 2006
  • Research & Ideas

Open Source Science: A New Model for Innovation

scientific problem solving? Yes, and it comes from an unexpected and unrelated corner of the universe: open source software development. That's the view of Karim R. Lakhani, an assistant professor at Harvard Business School with an extensive View Details
Keywords: by Martha Lagace
  • June 2006
  • Teaching Note

Vertex Pharmaceuticals: R&D Portfolio Management (A), (B), and (C) (TN)

By: Francesca Gino and Gary P. Pisano
Keywords: Investment Portfolio; Research and Development; Pharmaceutical Industry
Citation
Purchase
Related
Gino, Francesca, and Gary P. Pisano. "Vertex Pharmaceuticals: R&D Portfolio Management (A), (B), and (C) (TN)." Harvard Business School Teaching Note 606-145, June 2006.
  • 09 Feb 2018
  • Working Paper Summaries

Developing Novel Drugs

Keywords: by Joshua Krieger, Danielle Li, and Dimitris Papanikolaou; Pharmaceutical
  • 1999
  • Chapter

The Economics of Drug Discovery

By: Rebecca M. Henderson and Iain Cockburn
Keywords: Economics; Innovation and Invention; Research and Development; Pharmaceutical Industry
Citation
Read Now
Related
Henderson, Rebecca M., and Iain Cockburn. "The Economics of Drug Discovery." Chap. 5 in Pharmaceutical Innovation, edited by Ralph Landau, Basil Achilladelis, and Alexander Scriabine, 308–331. Philadelphia: Chemical Heritage Press, 1999.
  • September 2024
  • Article

Comprehensive Measurement of Biopharmaceutical R&D Investment

By: Amitabh Chandra, John Drum, Michael Daly, Henry Mirsberger, Samuel Spare, Ulrich Neumann, Silas Martin and Noam Kirson
Keywords: Research and Development; Investment; Pharmaceutical Industry
Citation
Purchase
Related
Chandra, Amitabh, John Drum, Michael Daly, Henry Mirsberger, Samuel Spare, Ulrich Neumann, Silas Martin, and Noam Kirson. "Comprehensive Measurement of Biopharmaceutical R&D Investment." Nature Reviews: Drug Discovery 23, no. 9 (September 2024): 652–653.
  • 2023
  • Working Paper

Evaluation and Learning in R&D Investment

By: Alexander P. Frankel, Joshua L. Krieger, Danielle Li and Dimitris Papanikolaou
We examine the role of spillover learning in shaping the value of exploratory versus incremental R&D. Using data from drug development, we show that novel drug candidates generate more knowledge spillovers than incremental ones. Despite being less likely to reach... View Details
Keywords: Research and Development; Forecasting and Prediction; Valuation; Pharmaceutical Industry
Citation
Read Now
Purchase
Related
Frankel, Alexander P., Joshua L. Krieger, Danielle Li, and Dimitris Papanikolaou. "Evaluation and Learning in R&D Investment." Harvard Business School Working Paper, No. 23-074, May 2023. (NBER Working Paper Series, No. 31290, May 2023.)
  • ←
  • 11
  • 12
  • …
  • 15
  • 16
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.